Iridex Corp

IRIX Nasdaq SEC CIK 1006045
Follow Iridex Weekly email: filings, results

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M$0$20M$40M$60MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$52.7M−$4.4M
FY25$48.7M−$8.9M
FY24$51.9M−$9.6M
FY23$57M−$7.5M
FY22$53.9M−$5.2M
FY21$36.3M−$6.3M
FY20$43.4M−$8.8M
FY19$42.6M−$12.8M
FY18$41.6M−$12.9M
FY17$46.2M−$11.7M
FY16$41.8M$474K
FY15$42.8M$10M
FY14$38.3M$2.2M
FY13$33.9M$1.4M
FY12$33.2M$2.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%−25%0%25%50%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2636.5%−4.9%−8.4%
FY2540.1%−17.1%−18.3%
FY2442%−19.3%−18.5%
FY2344.5%−13.2%−13.2%
FY2242.4%−14%−9.7%
FY2142.8%−18.1%−17.4%
FY2041.3%−20.7%−20.3%
FY1941%−30.2%−30.1%
FY1837.3%−31%−30.9%
FY1745.1%−5.6%−25.4%
FY1647.8%0.7%1.1%
FY1550%6%23.4%
FY1448.6%6.9%5.8%
FY1348.3%−2.5%4.2%
FY1249.1%5.8%7.9%
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0$5M$10MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26−$2.3M
FY25−$7.3M
FY24−$6.9M
FY23−$9.8M
FY22$8M
FY21−$3.3M
FY20−$8M
FY19−$10.5M
FY18−$4.1M
FY17−$1.2M
FY16−$1.5M
FY15$3.4M
FY14$387K
FY13−$1.5M
FY12$2M
Returned to shareholdersDividends paid and shares bought back
$0$2M$4M$6MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearBuybacks
FY26-
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19-
FY18-
FY17$59K
FY16$1.6M
FY15$4.7M
FY14$426K
FY13$2.8M
FY12$648K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Iridex
  • Healthcare median
−100%−50%0%50%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearIridexHealthcare median
FY26−8.4%−11.1%
FY25−18.3%−30.6%
FY24−18.5%−47%
FY23−13.2%−58%
FY22−9.7%−80.4%
FY21−17.4%−71.8%
FY20−20.3%−62.2%
FY19−30.1%−46.2%
FY18−30.9%−49.6%
FY17−25.4%−45.9%
FY161.1%−36%
FY1523.4%−37.8%
FY145.8%−35.5%
FY134.2%−37.1%
FY127.9%−29.1%